Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Gomez-Peralta F, Abreu C, Rizzo M. GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms. J Diabetes Complications 2023;37:108553.
PMID: 37385011


Privacy Policy